| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-Based Programs for Vaccination against HPV
|
Elbasha, Elamin H.
|
|
2009
|
12 |
Supplement 3 |
p. 697-707
11 p.
|
artikel
|
| 2 |
A Survey of Knowledge on Diabetes in the Central Region of Thailand
|
Pongmesa, Tipaporn
|
|
2009
|
12 |
Supplement 3 |
p. S110-S113
4 p.
|
artikel
|
| 3 |
Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests
|
Cleemput, Irina
|
|
2009
|
12 |
Supplement 3 |
p. 441-449
9 p.
|
artikel
|
| 4 |
Breaking the Silence: Exploring the Potential Effects of Explicit Instructions on Incorporating Income and Leisure in TTO Exercises
|
Krol, Marieke
|
|
2009
|
12 |
Supplement 3 |
p. 172-180
9 p.
|
artikel
|
| 5 |
Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods
|
Bojke, Laura
|
|
2009
|
12 |
Supplement 3 |
p. 739-749
11 p.
|
artikel
|
| 6 |
CN4 COST-EFFECTIVENESS OF PEMETREXED IN FIRST LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN PORTUGAL
|
Pinto, CG
|
|
2009
|
12 |
Supplement 3 |
p. A222-
1 p.
|
artikel
|
| 7 |
CN6 TREATMENT-RELATED TOXICITIES IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
|
Yood, MU
|
|
2009
|
12 |
Supplement 3 |
p. A225-
1 p.
|
artikel
|
| 8 |
CO3 INDIRECT SOCIAL COST OF MULTIPLE SCLEROSIS: RESULTS FROM A REAL-WORLD OBSERVATIONAL STUDY
|
Kirzinger, S
|
|
2009
|
12 |
Supplement 3 |
p. A233-A234
nvt p.
|
artikel
|
| 9 |
Comparative Analysis of Length of Stay, Total Costs, and Treatment Success between Intravenous Moxifloxacin 400 mg and Levofloxacin 750 mg among Hospitalized Patients with Community-Acquired Pneumonia
|
Friedman, Howard
|
|
2009
|
12 |
Supplement 3 |
p. 1135-1143
9 p.
|
artikel
|
| 10 |
Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 Preference-Based SF-6D in Chronic Kidney Disease
|
Davison, Sara N.
|
|
2009
|
12 |
Supplement 3 |
p. 340-345
6 p.
|
artikel
|
| 11 |
Confirmatory Factor Analysis and Sample Invariance of the Chinese Patient Satisfaction Questionnaire (ChPSQ-9) among Patients with Breast and Lung Cancer
|
Wong, Wing Sze
|
|
2009
|
12 |
Supplement 3 |
p. 597-605
9 p.
|
artikel
|
| 12 |
Cost-Effectiveness of Drug-Eluting Stents in a US Medicare Setting: A Cost-Utility Analysis with 3-Year Clinical Follow-Up Data
|
Bischof, Matthias
|
|
2009
|
12 |
Supplement 3 |
p. 649-656
8 p.
|
artikel
|
| 13 |
Cost-Effectiveness of New-Generation Oral Cholera Vaccines: A Multisite Analysis
|
Jeuland, Marc
|
|
2009
|
12 |
Supplement 3 |
p. 899-908
10 p.
|
artikel
|
| 14 |
Cost-Effectiveness of Using Clinical Risk Factors with and without DXA for Osteoporosis Screening in Postmenopausal Women
|
Mueller, Dirk
|
|
2009
|
12 |
Supplement 3 |
p. 1106-1117
12 p.
|
artikel
|
| 15 |
CS19 AUDITORIA BASEADA EM EVIDÊNCIAS (ABE): IMPACTO NO CUSTO DO TRATAMENTO QUIMIOTERÁPICO APÓS 3 ANOS DE IMPLANTA¸ÃO
|
Clark, LG
|
|
2009
|
12 |
Supplement 3 |
p. A491-
1 p.
|
artikel
|
| 16 |
CS11 COST-EFFECTIVENESS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE TREATMENT OF MAJOR DEPRESSION IN MEXICO
|
Idrovo, J
|
|
2009
|
12 |
Supplement 3 |
p. A487-
1 p.
|
artikel
|
| 17 |
CS15 ECONOMIC BURDEN ASSOCIATED WITH DOSE-TITRATION AT INITIATION TO MANAGED CARE IN PATIENTS WITH NON-PSYCHOTIC MAJOR DEPRESSIVE DISORDER
|
Camacho, F
|
|
2009
|
12 |
Supplement 3 |
p. A490-
1 p.
|
artikel
|
| 18 |
CS18 ECONOMIC EVALUATION OF BARIATRIC SURGERY AS TREATMENT FOR OBESITY AND ASSOCIATED COMORBIDITIES—ESTIMATION BY DISCRETE EVENT SIMULATION
|
Cabra, HA
|
|
2009
|
12 |
Supplement 3 |
p. A491-
1 p.
|
artikel
|
| 19 |
CV1 ASSOCIATION OF CARDIOMETABOLIC RISK FACTORS AND PREVALENT CARDIOVASCULAR EVENTS
|
Malone, DC
|
|
2009
|
12 |
Supplement 3 |
p. A7-
1 p.
|
artikel
|
| 20 |
DB2 PERSISTENCE WITH BASAL SUPPORTED ORAL THERAPY—COMPARISON OF INSULIN GLARGINE VERSUS NPH INSULIN
|
Quinzler, R
|
|
2009
|
12 |
Supplement 3 |
p. A234-
1 p.
|
artikel
|
| 21 |
Deriving a Patient-Based Utility Index from a Cancer-Specific Quality of Life Questionnaire
|
Grimison, Peter S.
|
|
2009
|
12 |
Supplement 3 |
p. 800-807
8 p.
|
artikel
|
| 22 |
Development of a New Questionnaire to Assess Patient Perceptions of Cancer-Related Fatigue: Item Generation and Item Reduction
|
Baró, Eva
|
|
2009
|
12 |
Supplement 3 |
p. 130-138
9 p.
|
artikel
|
| 23 |
DU2 RACIAL DIAPARITIES AND BARRIER TO DRUG UTILIZATION IN PATIENTS WITH DIABETES IN THE UNITED STATES
|
Seetasith, A
|
|
2009
|
12 |
Supplement 3 |
p. A3-
1 p.
|
artikel
|
| 24 |
Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer
|
Cella, David
|
|
2009
|
12 |
Supplement 3 |
p. 124-129
6 p.
|
artikel
|
| 25 |
Estimating the Danish Populations' Preferences for Pharmacogenetic Testing Using a Discrete Choice Experiment. The Case of Treating Depression
|
Herbild, Louise
|
|
2009
|
12 |
Supplement 3 |
p. 560-567
8 p.
|
artikel
|
| 26 |
Evaluating Minimal Important Differences for the FACT-Melanoma Quality of Life Questionnaire
|
Askew, Robert L.
|
|
2009
|
12 |
Supplement 3 |
p. 1144-1150
7 p.
|
artikel
|
| 27 |
Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study
|
Alonso, Jordi
|
|
2009
|
12 |
Supplement 3 |
p. 536-543
8 p.
|
artikel
|
| 28 |
Hypoactive Sexual Desire Disorder in Postmenopausal Women: Quality of Life and Health Burden
|
Biddle, Andrea K.
|
|
2009
|
12 |
Supplement 3 |
p. 763-772
10 p.
|
artikel
|
| 29 |
Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive
|
Valentine, William J.
|
|
2009
|
12 |
Supplement 3 |
p. 1-9
9 p.
|
artikel
|
| 30 |
MC1 VALORACIÓN SOCIAL DE LOS ESTADOS DE SALUD EQ-5D EN CHILE: ALCANCES METODOLÓGICOS
|
Valenzuela, P
|
|
2009
|
12 |
Supplement 3 |
p. A485-
1 p.
|
artikel
|
| 31 |
MD7 DOES MEDICARE HAVE AN IMPLICIT COST-EFFECTIVENESS THRESHOLD?
|
Chambers, J
|
|
2009
|
12 |
Supplement 3 |
p. A15-A16
nvt p.
|
artikel
|
| 32 |
MD2 RACIAL DISPARITIES IN ANTI-DEMENTIA MEDICATION, ANTIDEPRESSANT, AND ANTIPSYCHOTIC USE AMONG MEDICARE BENEFICIARIES WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
|
Lin, PJ
|
|
2009
|
12 |
Supplement 3 |
p. A12-
1 p.
|
artikel
|
| 33 |
MO4 BAYESIAN GENERALIZED LINEAR MODELLING OF THE RELATIONSHIP BETWEEN HEALTH ASSESSMENT QUESTIONNAIRE-DISABILITY INDEX AND HEALTH UTILITIES INDEX MARK III IN EARLY AND LATE RHEUMATOID ARTHRITIS: DATA FROM THE PREMIER AND ARMADA TRIALS
|
Vanness, D
|
|
2009
|
12 |
Supplement 3 |
p. A227-
1 p.
|
artikel
|
| 34 |
MO1 IMPACT OF INCLUDING CARDIOVASCULAR AND RESPIRATORY OUTCOMES ON ESTIMATES OF CLINICAL AND ECONOMIC BENEFITS OF INFLUENZA VACCINATION IN THE U.S. ELDERLY POPULATION
|
Gao, X
|
|
2009
|
12 |
Supplement 3 |
p. A13-
1 p.
|
artikel
|
| 35 |
MO5 THE USE OF SURVIVAL ANALYSES FOR COST-EFFECTIVENESS MODELS: AN EVALUATION OF METHODS USED IN NICE APPRAISALS
|
Guyot, P
|
|
2009
|
12 |
Supplement 3 |
p. A231-
1 p.
|
artikel
|
| 36 |
Multinational Trials—Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force Report
|
Wild, Diane
|
|
2009
|
12 |
Supplement 3 |
p. 430-440
11 p.
|
artikel
|
| 37 |
Patient Experiences of Continuity of Cancer Care: Development of a New Medical Care Questionnaire (MCQ) for Oncology Outpatients
|
Harley, Clare
|
|
2009
|
12 |
Supplement 3 |
p. 1180-1186
7 p.
|
artikel
|
| 38 |
PCN6 A COMPARISON OF CLINICAL EFFICACY AND SAFETY OF LENOGRASTIM AND FILGRASTIM IN THE STEM CELL MOBILIZATION
|
Pankiewicz, O
|
|
2009
|
12 |
Supplement 3 |
p. A257-
1 p.
|
artikel
|
| 39 |
PCN110 A RETROSPECTIVE CLAIMS DATABASE COMPARISON OF SORAFENIB AND SUNITINIB DOSING PATTERNS IN PATIENTS WITH RENAL CELL CARCINOMA (RCC)
|
Keefe, S
|
|
2009
|
12 |
Supplement 3 |
p. A57-
1 p.
|
artikel
|
| 40 |
PCN19 BUDGET IMPACT ANALYSIS OF SARGRAMOSTIM USE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA
|
Toy, EL
|
|
2009
|
12 |
Supplement 3 |
p. A39-
1 p.
|
artikel
|
| 41 |
PCN96 COLORECTAL CANCER SCREENING: COST-EFFECTIVENESS OF CT COLONOGRAPHY
|
Sweet, A
|
|
2009
|
12 |
Supplement 3 |
p. A275-
1 p.
|
artikel
|
| 42 |
PCN82 COST-EFFECTIVENESS ANALYSIS OF HPV VACCINATION IN SLOVENIA
|
Obradovic, M
|
|
2009
|
12 |
Supplement 3 |
p. A272-
1 p.
|
artikel
|
| 43 |
PCN99 COST-EFFECTIVENESS ANALYSIS OF IMIQUIMOD VERSUS NO TREATMENT IN PATIENTS WITH SUPERFICIAL BASAL CELL CARCINOMA AND CONTRAINDICATION TO SURGICAL INTERVENTION/CRYOTHERAPY
|
Walczak, J
|
|
2009
|
12 |
Supplement 3 |
p. A275-A276
nvt p.
|
artikel
|
| 44 |
PCN50 COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER
|
Jones, S
|
|
2009
|
12 |
Supplement 3 |
p. A45-
1 p.
|
artikel
|
| 45 |
PCN53 COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINE FOR PREVENTION OF CERVICAL CANCER IN TAIWAN
|
Liu, PH
|
|
2009
|
12 |
Supplement 3 |
p. A46-
1 p.
|
artikel
|
| 46 |
PCN22 COST-EFFECTIVENESS OF PALONOSETRON FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING ASSOCIATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY
|
Rely, K
|
|
2009
|
12 |
Supplement 3 |
p. A496-
1 p.
|
artikel
|
| 47 |
PCN41 COST-SAVINGS ASSOCIATED WITH BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BCG) COMPARED WITH CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CVC) IN PATIENTS WITH ADVANCED OR RECURRENT NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY
|
Heigener, D
|
|
2009
|
12 |
Supplement 3 |
p. A263-A264
nvt p.
|
artikel
|
| 48 |
PCN9 DEVELOPMENT OF SERUM TESTS FOR COLORECTAL CANCER SCREENING
|
Schiff, L
|
|
2009
|
12 |
Supplement 3 |
p. A257-
1 p.
|
artikel
|
| 49 |
PCN63 DIFFERENT TREATMENT PATTERNS COSTS IN METASTATIC BREAST CANCER (MBC) EXPOSED TO ANTHRACYCLINHES AND TAXANES (AT) IN 3 DIFFERENT MEXICAN PUBLIC HOSPITALS
|
Juarez-Garcia, A
|
|
2009
|
12 |
Supplement 3 |
p. A48-
1 p.
|
artikel
|
| 50 |
PCN127 DYNAMIC CONTRAST-ENHANCED ULTRASOUND WITH QUANTIFICATION TO ASSESS TARGETED TREATMENT EFFICACY: RESULTS OF A MULTI-CENTRIC PROSPECTIVE COST STUDY
|
Bonastre, J
|
|
2009
|
12 |
Supplement 3 |
p. A281-
1 p.
|
artikel
|
| 51 |
PCN8 EVALUACIÓN DE LA CARGA DE ENFERMEDAD POR EL VIRUS DEL PAPILOMA HUMANO EN BOGOTÁ, COLOMBIA
|
de La Hoz, F
|
|
2009
|
12 |
Supplement 3 |
p. A494-
1 p.
|
artikel
|
| 52 |
PCN5 GAINS ASSOCIATED WITH CLINICAL EXAMS AND MAMMOGRAPHIC SCREENING FOR WOMEN ABOVE 40 YEARS OF AGE
|
Caleffi, M
|
|
2009
|
12 |
Supplement 3 |
p. A36-
1 p.
|
artikel
|
| 53 |
PCN77 HEALTH CARE RESOURCE UTILIZATION ASSOCIATED WITH ESCALATING IMATINIB VERSUS SWITCHING TO DASATINIB IN PATIENTS WITH CHRONIC MYELEGENOUS LEUKEMIA
|
Yu, AP
|
|
2009
|
12 |
Supplement 3 |
p. A50-A51
nvt p.
|
artikel
|
| 54 |
PCN145 HEALTH ECONOMIC REVIEW OF NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT IN THE UNITED STATES
|
Munakata, J
|
|
2009
|
12 |
Supplement 3 |
p. A284-A285
nvt p.
|
artikel
|
| 55 |
PCN130 HEALTH UTILITIES OF CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN DFCI 95-01 RANDOMIZED CLINICAL TRIAL
|
Furlong, W
|
|
2009
|
12 |
Supplement 3 |
p. A282-
1 p.
|
artikel
|
| 56 |
PCN65 INPATIENT COST AND REIMBURSEMENT FOR PATIENTS WITH PROGRESSIVE MALIGNANT THORACIC NEOPLASM IN GERMANY
|
Krych, M
|
|
2009
|
12 |
Supplement 3 |
p. A268-
1 p.
|
artikel
|
| 57 |
PCN94 LEVEL OF BREAST CANCER EARLY DETECTION AWARENESS OF BRAZILIAN WOMEN
|
Caleffi, M
|
|
2009
|
12 |
Supplement 3 |
p. A54-
1 p.
|
artikel
|
| 58 |
PCN126 LOSS OF WORK ACTIVITY AND PRODUCTIVITY IN CAREGIVERS ATTENDING TO PATIENTS WITH ADVANCED RENAL CELL CARCINOMA TREATED WITH TEMSIROLIMUS OR INTERFERON-ALFA: EVALUATIONS FROM A PHASE 3 RANDOMIZED TRAIL
|
Yang, S
|
|
2009
|
12 |
Supplement 3 |
p. A281-
1 p.
|
artikel
|
| 59 |
PCN38 NUMBER NEEDED TO TREAT (NNT) TO AVOID ONE GASTROINTESTINAL STROMAL TUMOUR (GIST) RECURRENCE IN BRAZIL. COST COMPARISON AND BUDGET IMPACT ANALYSIS OF ADJUVANT TREATMENT WITH IMATINIB
|
Valentim, J
|
|
2009
|
12 |
Supplement 3 |
p. A263-
1 p.
|
artikel
|
| 60 |
PCN155 “PATIENT ACCESS SCHEMES”—THE USE OF RISK-SHARING IN THE UK
|
Carroll, SM
|
|
2009
|
12 |
Supplement 3 |
p. A286-A287
nvt p.
|
artikel
|
| 61 |
PCN113 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS 5-FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE FIRST LINE TREATMENT OF METASTASIS COLORECTAL CANCER IN TAIWAN
|
Chen, HH
|
|
2009
|
12 |
Supplement 3 |
p. A278-
1 p.
|
artikel
|
| 62 |
PCN23 PHARMACOEPIDEMIOLOGY OF PATIENTS TREATED WITH TEMOZOLOMIDE
|
Brignone, M
|
|
2009
|
12 |
Supplement 3 |
p. A260-
1 p.
|
artikel
|
| 63 |
PCN91 PROVISION OF QUALITY OF LIFE INFORMATION AND PHYSICIAN TRUST AMONG FAMILIES OF CHILDREN WITH LIFE-LIMITED CONDITIONS
|
Huang, IC
|
|
2009
|
12 |
Supplement 3 |
p. A53-
1 p.
|
artikel
|
| 64 |
PCN170 PUBLIC REGULATION OF THE CANCER DRUGS MARKET IN FRENCH HOSPITALS
|
Degrassat-Théas, A
|
|
2009
|
12 |
Supplement 3 |
p. A289-
1 p.
|
artikel
|
| 65 |
PCN25 REVISIÓN SISTEMÁTICA Y EVALUACIÓN ECONÓMICA DE LA ABLACIÓN POR RADIOFRECUENCIA EN TUMORES HEPÁTICOS
|
Callejo, D
|
|
2009
|
12 |
Supplement 3 |
p. A497-
1 p.
|
artikel
|
| 66 |
PCN51 THE COSTS OF BREAST CANCER PRIOR TO AND FOLLOWING DIAGNOSIS
|
Broeckx, S
|
|
2009
|
12 |
Supplement 3 |
p. A266-
1 p.
|
artikel
|
| 67 |
PCN36 THE ESTIMATED IMPACT OF IN VITRO BIOMARKERS ON THE COSTEFFECTIVENESS OF POPULATION-WIDE COLORECTAL CANCER SCREENING
|
Wittenberg, GM
|
|
2009
|
12 |
Supplement 3 |
p. A43-
1 p.
|
artikel
|
| 68 |
PCN1 TIME DELAY OF OCCURRENCE OF SECONDARY MALIGNANT TUMORS AFTER PRIMARY BREAST CANCER IN THE FEMALE POPULATION OF HUNGARY BETWEEN 2003 AND 2007
|
Gazdag, L
|
|
2009
|
12 |
Supplement 3 |
p. A36-
1 p.
|
artikel
|
| 69 |
PCV167 A CLUSTER RANDOMIZED CONTROLLED TRIAL TO EVALUATE AN AMBULATORY PRIMARY CARE MANAGEMENT PROGRAM FOR PATIENTS WITH DYSLIPIDEMIA: TEAM STUDY
|
Lalonde, L
|
|
2009
|
12 |
Supplement 3 |
p. A344-
1 p.
|
artikel
|
| 70 |
PCV18 ADHERENCE TO STATIN TREATMENT AND ACHIEVING LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) GOALS IN AN EMPLOYEE POPULATION
|
Chen, CY
|
|
2009
|
12 |
Supplement 3 |
p. A143-A144
nvt p.
|
artikel
|
| 71 |
PCV149 ASSESSMENT OF QUALITY OF LIFE AMONG PATIENTS WITH HYPERTENSION AND DIABETES TYPE 2
|
Turska, W
|
|
2009
|
12 |
Supplement 3 |
p. A341-
1 p.
|
artikel
|
| 72 |
PCV94 ASSESSMENT OF THE STATUS OF HYPERTENSION MANAGEMENT IN NEWLY DIAGNOSED AND ESTABLISHED HYPERTENSION PATIENTS IN PRIMARY CARE PRACTICE
|
Kim, J
|
|
2009
|
12 |
Supplement 3 |
p. A158-
1 p.
|
artikel
|
| 73 |
PCV60 BUDGET IMPACT MODEL FOR DETERMINING THE HOSPITAL COSTS OF INTRODUCING PRASUGREL FOR THE LONG TERM TREATMENT OF ACUTE CORONARY SYNDROME TREATED BY PERCUTANEOUS CORONARY INTERVENTION IN FRANCE
|
Chevreul, K
|
|
2009
|
12 |
Supplement 3 |
p. A323-
1 p.
|
artikel
|
| 74 |
PCV15 COMBINED OPTIMAL LIPID VALUE GOAL ATTAINMENT AFTER TREATMENT INITIATION WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS EZETIMIBE PLUS SIMVASTATIN COMBINATION THERAPY IN A MANAGED CARE PATIENT POPULATION WITH PRIOR CARDIOVASCULAR DISEASE IN THE UNITED STATES
|
Balu, S
|
|
2009
|
12 |
Supplement 3 |
p. A314-
1 p.
|
artikel
|
| 75 |
PCV73 COST–ANALYSIS OF STROKE PATIENTS WITH THE INTEGRATED WESTERN AND ORIENTAL MEDICAL TREATMENT IN SOUTH KOREA
|
Ku, MJ
|
|
2009
|
12 |
Supplement 3 |
p. A326-
1 p.
|
artikel
|
| 76 |
PCV56 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE 150 MG FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY THAT HAVE MODERATE IMPAIRMENT OF RENAL FUNCTION
|
Wolowacz, S
|
|
2009
|
12 |
Supplement 3 |
p. A151-
1 p.
|
artikel
|
| 77 |
PCV87 COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND PLANNED PCI: RESULTS FROM THE TRITON-TIMI 38 TRIAL FROM THE GERMAN PERSPECTIVE
|
Mahoney, EM
|
|
2009
|
12 |
Supplement 3 |
p. A328-A329
nvt p.
|
artikel
|
| 78 |
PCV18 COSTO-EFECTIVIDAD DE ETEXILATO DE DABIGATRAN EN LA PROFILAXIS DE LA ENFERMEDAD TROMBOEMBOLICA VENOSA (ETV) ASOCIADA CON CIRUGIA DE CADERA EN EL PACIENTE ADULTO EN EL INSTITUTO MEXICANO DEL SEGURO SOCIAL (IMSS)
|
Ledezma-Gómez, H
|
|
2009
|
12 |
Supplement 3 |
p. A503-
1 p.
|
artikel
|
| 79 |
PCV63 COST OF CARDIOVASCULAR DISEASE IN KOREA: INCIDENCE-BASED APPROACH
|
Lee, YS
|
|
2009
|
12 |
Supplement 3 |
p. A324-
1 p.
|
artikel
|
| 80 |
PCV132 DIFFERENCES IN PERSISTENCE BETWEEN CCBS WHEN COMBINED WITH AN A2RA OR AN ACE ANTIHYPERTENSIVE IN AUSTRALIA
|
Ortiz, M
|
|
2009
|
12 |
Supplement 3 |
p. A338-
1 p.
|
artikel
|
| 81 |
PCV91 DISPARITIES IN CORONARY ARTERY DISEASE CARE AMONG ENROLLEES WITH AARP MEDICARE SUPPLEMENT INSURANCE
|
Hawkins, K
|
|
2009
|
12 |
Supplement 3 |
p. A157-A158
nvt p.
|
artikel
|
| 82 |
PCV59 ECONOMIC ANALYSIS OF THE ENDEAVOR DRUG-ELUTING STENT VS. THE DRIVER BARE METAL STENT: RESULTS FROM THE ENDEAVOR II TRIAL
|
Eisenstein, EL
|
|
2009
|
12 |
Supplement 3 |
p. A152-
1 p.
|
artikel
|
| 83 |
PCV118 ECONOMIC EVALUATION OF INHALED ILOPROST IN PRIMARY PULMONARY HYPERTENSION IN THE UK
|
Ashley, D
|
|
2009
|
12 |
Supplement 3 |
p. A335-
1 p.
|
artikel
|
| 84 |
PCV15 EFFECT OF STATIN THERAPY ON RISK OF CORONARY DISEASE IN PRIMARY AND SECONDARY PREVENTION TRIALS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
|
Liu, JA
|
|
2009
|
12 |
Supplement 3 |
p. A143-
1 p.
|
artikel
|
| 85 |
PCV1 EVALUATING CLINICAL OUTCOMES OF AN EMPLOYER SPONSERED MULTI CENTER DIABETES AND HYPERTENSION MEDICATION THERAPY MANAGEMENT PROGRAM (MTMP)
|
Pinto, SL
|
|
2009
|
12 |
Supplement 3 |
p. A140-
1 p.
|
artikel
|
| 86 |
PCV32 HEALTH ECONOMICS EVALUATION ON PERCUTANEOUS CORONARY INTERVENTION(PCI) IN CHINA
|
Han, F
|
|
2009
|
12 |
Supplement 3 |
p. A146-
1 p.
|
artikel
|
| 87 |
PCV135 HEALTH STATUS IN AN ARGENTINIAN POPULATION SURVEY : RESULTS FROM THE NATIONAL RISK FACTOR SURVEY
|
Augustovski, FA
|
|
2009
|
12 |
Supplement 3 |
p. A338-
1 p.
|
artikel
|
| 88 |
PCV42 INCREMENTAL COST-EFFECTIVENESS ANALYSIS OF ANGIOTENSIN RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS IN A US MANAGED CARE POPULATION
|
Miller, LA
|
|
2009
|
12 |
Supplement 3 |
p. A148-
1 p.
|
artikel
|
| 89 |
PCV101 IS PRASUGREL COST-EFFECTIVE RELATIVE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FROM THE PERSPECTIVE OF THE GERMAN HEALTH CARE SYSTEM? A MODEL-BASED ANALYSIS
|
Davies, A
|
|
2009
|
12 |
Supplement 3 |
p. A331-
1 p.
|
artikel
|
| 90 |
PCV29 OUTCOMES ASSESSMENT IN LOW & HIGH RISK P.T.C.A. PATIENTS
|
Singh, S
|
|
2009
|
12 |
Supplement 3 |
p. A317-
1 p.
|
artikel
|
| 91 |
PCV46 PERFLUTREN PROTEIN-TYPE A MICROSPHERES INJECTABLE SUSPENSION, USP DOES NOT INCREASE MORTALITY IN CRITICALLY ILL PATIENTS: RESULTS FROM A RETROSPECTIVE PROPENSITY-MATCHED CASE-CONTROL STUDY
|
Main, M
|
|
2009
|
12 |
Supplement 3 |
p. A320-
1 p.
|
artikel
|
| 92 |
PCV1 PREDICTED CARDIOVASCULAR EVENT REDUCTION WITH THE COADMINISTRATION OF FENOFIBRIC ACID AND LOW- OR MODERATEDOSE STATINS IN HISPANIC PATIENTS WITH MIXED DYSLIPIDEMIA
|
Webb, SF
|
|
2009
|
12 |
Supplement 3 |
p. A500-
1 p.
|
artikel
|
| 93 |
PCV74 PREDICTED REDUCTION IN HOSPITAL DAYS AND ASSOCIATED COSTS AMONG MANAGED CARE PRIMARY AND SECONDARY RISK MIXED DYSLIPIDEMIA PATIENTS TREATED WITH FIXED DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN COMBINATION THERAPY
|
Simko, RJ
|
|
2009
|
12 |
Supplement 3 |
p. A155-
1 p.
|
artikel
|
| 94 |
PCV104 THE COST-EFFECTIVENESS ANALYSIS IN SCREENING OF DEEP VEIN THROMBOSIS IN A CLINICAL LABORATORY
|
Bogavac-Stanojevic, N
|
|
2009
|
12 |
Supplement 3 |
p. A332-
1 p.
|
artikel
|
| 95 |
PCV108 USE OF RENIN SYSTEM AGENTS AMONG HYPERTENSION PATIENTS WITH RENAL DISEASE IN A MANAED CARE SETTING
|
Stern, L
|
|
2009
|
12 |
Supplement 3 |
p. A161-
1 p.
|
artikel
|
| 96 |
PCV12 WHAT IS THE IMPACT OF ARBS VERSUS OTHER ANTI-HYPERTENSIVES ON CV-EVENTS IN HYPERTENSIVE PATIENTS?
|
Petrella, RJ
|
|
2009
|
12 |
Supplement 3 |
p. A313-
1 p.
|
artikel
|
| 97 |
PDB10 A COMPARISON OF ECONOMIC OUTCOMES BETWEEN ADHERENT AND NONADHERENT PATIENTS TREATED WITH ORAL ANTIDIABETIC MEDICATIONS
|
Hansen, RA
|
|
2009
|
12 |
Supplement 3 |
p. A98-
1 p.
|
artikel
|
| 98 |
PDB45 ASSESSING UTILITIES AND DISUTILITIES FOR TYPE 2 DIABETES TREATMENT-RELATED ATTRIBUTES IN AN ASIAN POPULATION
|
Bruhn, D
|
|
2009
|
12 |
Supplement 3 |
p. A410-
1 p.
|
artikel
|
| 99 |
PDB24 COMPARISON OF GLUCOMETERS USED FOR SELF-MONITORING BLOOD GLUCOSE AMONG DIABETIC PATIENTS: A COST MINIMIZATION APPROACH.
|
Goyal, R
|
|
2009
|
12 |
Supplement 3 |
p. A101-
1 p.
|
artikel
|
| 100 |
PDB10 DIFFERENT PERSISTENCE WITH A BASAL SUPPORTED ORAL THERAPY (BOT) LEADS TO UNEQUAL DISTRIBUTIONS OF INSULIN TREATMENT REGIMENS IN TYPE-2-DIABETICS
|
Reichelt, A
|
|
2009
|
12 |
Supplement 3 |
p. A403-
1 p.
|
artikel
|
| 101 |
PDB27 DIRECT COST OF DIABETES IN OPD CLINICS OF PAKISTAN
|
Khowaja, LA
|
|
2009
|
12 |
Supplement 3 |
p. A101-A102
nvt p.
|
artikel
|
| 102 |
PDB62 ECONOMIC IMPACT OF COMPLIANCE AND PERSISTENCE TO TREATMENT WITH ANTIDIABETES MEDICATION IN T2DM—A SYSTEMATIC REVIEW
|
Breitscheidel, L
|
|
2009
|
12 |
Supplement 3 |
p. A413-
1 p.
|
artikel
|
| 103 |
PDB76 ETHICAL ANALYSES IN HEALTH TECHNOLOGY ASSESSMENTS OF DIABETES TREATMENTS
|
Kaas, C
|
|
2009
|
12 |
Supplement 3 |
p. A416-
1 p.
|
artikel
|
| 104 |
PDB7 HOSPITALIZACIONES POR INSUFICIENCIA CARDÍACA EN PERSONAS CON DIABETES: LOS COSTOS DE SU PREVENCIÓN VS. LOS DE SU TRATAMIENTO
|
Caporale, JE
|
|
2009
|
12 |
Supplement 3 |
p. A506-
1 p.
|
artikel
|
| 105 |
PDB13 MEDICATION PATTERN AND RISK OF STROKE AMONG TYPE II DIABETES MELLITUS IN TAIWAN-A POPULATION-BASED STUDY
|
Wu, CS
|
|
2009
|
12 |
Supplement 3 |
p. A403-
1 p.
|
artikel
|
| 106 |
PDB42 PERCEPTION VERSUS REALITY-CATEGORISATION OF PATIENT WEIGHT BY TYPE 2 DIABETES (T2DM) PATIENTS AND THEIR PHYSICIANS IN THE US AND EUROPE
|
Stahl, E
|
|
2009
|
12 |
Supplement 3 |
p. A104-A105
nvt p.
|
artikel
|
| 107 |
PDB28 THE COST-EFFECTIVENESS ANALYSIS OF VIDALGLIPTIN IN TYPE 2 DIABETES IN POLAND
|
Walczak, J
|
|
2009
|
12 |
Supplement 3 |
p. A406-
1 p.
|
artikel
|
| 108 |
PDB56 THE EFFECT OF VALUE-BASED INSURANCE DESIGN ON ADHERENCE TO DIABETES MEDICATIONS: A MATCHED DIFFERENCE IN DIFFERENCE EVALUATION
|
Zeng, F
|
|
2009
|
12 |
Supplement 3 |
p. A107-
1 p.
|
artikel
|
| 109 |
PDB59 USING THE ECHO MODEL TO EXAMINE THE EFFECT OF AN EMPLOYER-SPONSORED PHARMACIST PROVIDED DIABETES MTM PROGRAM ON OUTCOMES
|
Pinto, SL
|
|
2009
|
12 |
Supplement 3 |
p. A412-
1 p.
|
artikel
|
| 110 |
PGI15 ADULT CANADIANS SUFFERING FROM ACID RELATED DISEASES: PATIENT REPORTED ATTITUDES, PERCEPTIONS, AND IMPACT ON THEIR LIFE
|
Beamer, B
|
|
2009
|
12 |
Supplement 3 |
p. A60-
1 p.
|
artikel
|
| 111 |
PGI3 COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
|
Salinas Escudero, G
|
|
2009
|
12 |
Supplement 3 |
p. A508-
1 p.
|
artikel
|
| 112 |
PGI12 THE EFFECT OF A PRIOR AUTHORIZATION PROGRAM FOR PROTON-PUMP INHIBITORS ON MEDICATION PERSISTENCE AMONG THE ELDERLY
|
Devine, JW
|
|
2009
|
12 |
Supplement 3 |
p. A60-
1 p.
|
artikel
|
| 113 |
PG15 PREDICTORS FOR RESPONSE TO PRUCALOPRIDE IN PATIENTS WITH CHRONIC CONSTIPATION
|
Dubois, D
|
|
2009
|
12 |
Supplement 3 |
p. A346-
1 p.
|
artikel
|
| 114 |
PG121 TREATMENT OF CHRONIC HEPATITIS C WHICH DO NOT FOLLOW CLINICAL GUIDELINES IS INCREASING DIRECT MEDICAL COSTS
|
Lukac, M
|
|
2009
|
12 |
Supplement 3 |
p. A349-
1 p.
|
artikel
|
| 115 |
PHC1 COST-EFFECTIVENESS COMPARISON OF TENSION FREE VERSUS TENSION METHODS: OF INGUINAL HERNIA REPAIR IN BRAZIL
|
Plisko, R
|
|
2009
|
12 |
Supplement 3 |
p. A508-
1 p.
|
artikel
|
| 116 |
PHC8 REGIONAL DISPARITIES AND ECONOMIC OUTCOMES ASSOCIATED WITH MINIMALLY INVASIVE AND CONVENTIONAL SURGERIES OF THE CHEST, ABDOMEN, AND PELVIS
|
Moore, M
|
|
2009
|
12 |
Supplement 3 |
p. A63-
1 p.
|
artikel
|
| 117 |
PHP14 A POLICY ANALYSIS OF THE PORTUGUESE GENERIC MEDICINES MARKET
|
Simoens, S
|
|
2009
|
12 |
Supplement 3 |
p. A240-
1 p.
|
artikel
|
| 118 |
PHP31 A POLICY FRAMEWORK FOR FUNDING DRUGS FOR RARE DISEASES
|
Clarke, J
|
|
2009
|
12 |
Supplement 3 |
p. A243-
1 p.
|
artikel
|
| 119 |
PHP17 CAN ELECTRONIC NOTIFICATIONS ABOUT SUBSTITUTES CHANGE PHYSICIANS' DRUG PRESCRIPTION HABITS? DEFINITELY YES!
|
Zuker, A
|
|
2009
|
12 |
Supplement 3 |
p. A240-
1 p.
|
artikel
|
| 120 |
PHP92 COMPARISON OF THE TIME TO PREPARE CONTRAST MEDIA INJECTION IN CT SCAN EXAM WITH PREFILLED SYRINGES AND BOTTLES IN 7 EUROPEAN COUNTRIES
|
Lafuma, A
|
|
2009
|
12 |
Supplement 3 |
p. A254-
1 p.
|
artikel
|
| 121 |
PHP56 COMPRISON OF NOTIFIABLE DISEASES SURVELLIANCE WEBSITES OF FOUR COUNTRIES
|
Agarwal, SJ
|
|
2009
|
12 |
Supplement 3 |
p. A88-A89
nvt p.
|
artikel
|
| 122 |
PHP17 DECENTRALIZATION AND ORGANIZATIONAL REFORM IN IRANIAN PUBLIC HOSPITALS AFFILIATED WITH MINISTRY OF HEALTH
|
Jafarisirizi, M
|
|
2009
|
12 |
Supplement 3 |
p. A511-
1 p.
|
artikel
|
| 123 |
PHP12 HOW NON-REFERRAL OUTPATIENT CO-PAYMENT IN TAIWAN IMPACTS ON PATIENTS' OUT-OF-POCKET COSTS AND PRESCRIPTION PATTERNS
|
Chen, LC
|
|
2009
|
12 |
Supplement 3 |
p. A81-
1 p.
|
artikel
|
| 124 |
PHP88 IDENTIFYING KEY DECISION PATHWAYS IN HEALTH TECHNOLOGY ASSESSMENT AROUND THE WORLD
|
Sullivan, N
|
|
2009
|
12 |
Supplement 3 |
p. A95-
1 p.
|
artikel
|
| 125 |
PHP91 MEDICARE PART D'S EFFECT ON PRESCRIBING VOLUME: AVERAGE MONTHLY UTILIZATION OF SELECTED HIGH USE DRUGS IN THE PROTECTED CLASSES BY DIFFERENT SPECIALTIES
|
White, C
|
|
2009
|
12 |
Supplement 3 |
p. A95-
1 p.
|
artikel
|
| 126 |
PHP27 OPTIMIZING THE USE OF MEDICATION IN THE INTRAVENOUS COMPOUND CENTER OF THE CMNO
|
Lomelí García, M
|
|
2009
|
12 |
Supplement 3 |
p. A83-
1 p.
|
artikel
|
| 127 |
PHP61 POSITIVE DRUG LIST IN BULGARIA—5 YEARS LATER
|
Ivanova, AD
|
|
2009
|
12 |
Supplement 3 |
p. A248-
1 p.
|
artikel
|
| 128 |
PHP74 RED BLOOD CELL TRANSFUSION PRACTICES IN VA INTENSIVE CARE UNITS: HOW DO THEY VARY FOR PATIENTS WITH HEART AND CHRONIC KIDNEY DISEASE?
|
Ding, YY
|
|
2009
|
12 |
Supplement 3 |
p. A92-
1 p.
|
artikel
|
| 129 |
PHP75 SCANNING THE HORIZON FOR NEW AND EMERGING OMIC TECHNOLOGIES
|
Benguria-Arrate, G
|
|
2009
|
12 |
Supplement 3 |
p. A251-
1 p.
|
artikel
|
| 130 |
PHP78 THE ROLE OF HTA AGENCY IN DRUG REIMBURSEMENT DECISION-MAKING PROCESS IN POLAND (HTA IMPACT)
|
Kolasa, K
|
|
2009
|
12 |
Supplement 3 |
p. A251-
1 p.
|
artikel
|
| 131 |
PHP45 VARIABILITY OF FEES IN THE FIELD OF PHYSICAL THERAPY IN THE AUSTRIAN CONTRACT PHYSICIANS' AND INSTITUTES' SECTOR
|
Wilbacher, I
|
|
2009
|
12 |
Supplement 3 |
p. A87-
1 p.
|
artikel
|
| 132 |
PHP31 VARIABILITY OF FEES IN THE FIELD OF ULTRASOUND IN THE AUSTRIAN CONTRACTED PHYSICIANS' AND INSTITUTES' SECTOR
|
Weisser, A
|
|
2009
|
12 |
Supplement 3 |
p. A84-
1 p.
|
artikel
|
| 133 |
PIH15 AN ECONOMIC EVALUATION OF DROSPIRENONE 2 MG / ESTRADIOL 1.033 MG VERSUS TIBOLONE 2.5MG IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH GRADE 1 OR 2 HYPERTENSION IN KOREA
|
Jung, S
|
|
2009
|
12 |
Supplement 3 |
p. A293-
1 p.
|
artikel
|
| 134 |
PIH40 ASSESSING WORK PRODUCTIVITY IMPAIRMENT IN PREMENSTRUAL SYNDROME AND PREMENSTRUAL DYSPHRORIC DISORDER
|
Hammond, GC
|
|
2009
|
12 |
Supplement 3 |
p. A169-
1 p.
|
artikel
|
| 135 |
PIH8 AUTOPERCEPCIÓN DEL ESTADO SALUD DE LA POBLACIÓN ADULTA DE LA REGIÓN METROPOLITANA EN CHILE: UNA APLICACIÓN DE EQ-5D Y DE LA ESCALA VISUAL ANALOGA
|
Valenzuela, P
|
|
2009
|
12 |
Supplement 3 |
p. A514-
1 p.
|
artikel
|
| 136 |
PIH29 COMPARISON OF ADHERENCE, PERSISTENCE AND MEDICATION WASTAGE IN 30-DAY VERSUS 90-DAY REFILL CHANNELS
|
Vats, V
|
|
2009
|
12 |
Supplement 3 |
p. A167-
1 p.
|
artikel
|
| 137 |
PIH15 COST EFFECTIVENESS ANALYSIS OF GOSERELIN EMPIRIC THERAPY FOR DEEP ENDOMETRIOSIS TREATMENT
|
Araujo, D
|
|
2009
|
12 |
Supplement 3 |
p. A164-
1 p.
|
artikel
|
| 138 |
PIH43 HOURLY AND ANNUAL OBJECTIVE PRODUCTIVITY (PRESENTEEISM) ACROSS SEVERAL DISEASES: BIPOLAR DISORDER, OTHER MENTAL DISORDERS, CHRONIC CONSTIPATION, FUNCTIONAL DYSPEPSIA, GERD, GOUT, AND INSOMNIA
|
Brook, RA
|
|
2009
|
12 |
Supplement 3 |
p. A169-A170
nvt p.
|
artikel
|
| 139 |
PIH1 PERCEPTION OF PAIN AFTER CAESAREAN SECTION FROM THE POINT OF VIEW OF PUERPERAL MOTHERS
|
Kovács, E
|
|
2009
|
12 |
Supplement 3 |
p. A290-
1 p.
|
artikel
|
| 140 |
PIH35 THE APPLICATIONS OF GEOGRAPHIC INFORMATION SYSTEM TO QUALITY OF LIFE STUDIES: USING TAIWAN AS AN EXAMPLE
|
Yang, JJ
|
|
2009
|
12 |
Supplement 3 |
p. A296-
1 p.
|
artikel
|
| 141 |
PIH13 THE IMPACT OF FAMILY PHYSICIAN PROGRAM ON HEALTH INDICATORS IN IRAN (2003–2007)
|
Barati, O
|
|
2009
|
12 |
Supplement 3 |
p. A515-
1 p.
|
artikel
|
| 142 |
PIN12 BUDGET IMPACT ANALYSIS OF THREE CANDINS IN THE TREATMENT OF INVASIVE CANDIDIASIS IN ADULT NON- NEUTROPENIC PATIENTS IN SPAIN
|
Garcia, M
|
|
2009
|
12 |
Supplement 3 |
p. A419-
1 p.
|
artikel
|
| 143 |
PIN58 COST-EFFECTIVENESS OF ETRAVIRINE IN SWEDEN IN TREATMENT-EXPERIENCED HIV-I-INFECTED ADULTS WITH EVIDENCE OF NNRTI RESISTANCE AND AT LEAST 3 PI MUTATIONS
|
Moeremans, K
|
|
2009
|
12 |
Supplement 3 |
p. A428-
1 p.
|
artikel
|
| 144 |
PIN27 COST-EFFECTIVENESS OF LINEZOLID VS. VANCOMYCIN AND TEICOPLANIN IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS IN CZECH REPUBLIC
|
Suchankova, E
|
|
2009
|
12 |
Supplement 3 |
p. A422-
1 p.
|
artikel
|
| 145 |
PIN35 COST-EFFECTIVENESS OF MARAVIROC FOR HIV IN MEXICO
|
Contreras-Hernandez, I
|
|
2009
|
12 |
Supplement 3 |
p. A116-
1 p.
|
artikel
|
| 146 |
PIN51 COST-EFFECTIVENESS STUDY OF THE USE OF DAPTOMYCIN VERSUS VANCOMYCIN IN INFECTIVE ENDOCARDITIS AND BACTEREMIA TREATMENT IN PUBLIC HEALTH INSTITUTIONS IN MEXICO
|
Soria-Cedillo, IF
|
|
2009
|
12 |
Supplement 3 |
p. A427-
1 p.
|
artikel
|
| 147 |
PIN50 DRUG UTILIZATION REVIEW OF ANTIMICROBIAL DRUGS IN AN OUTPATIENT PRIVATE PEDIATRIC SETTING
|
Gupta, AS
|
|
2009
|
12 |
Supplement 3 |
p. A119-
1 p.
|
artikel
|
| 148 |
PIN14 EVALUACIÓN DE COSTO EFECTIVIDAD COMPARATIVO DE QUATRO ESQUEMAS DE TRATAMIENTO DE INFECCIÓN URINARIA BAJA EN MUJERESJÓVENES, IMPACTO ECONÓMICO EN UN ENTORNO DE SALUD MUNICIPAL DE CARACAS, VENEZUELA
|
Castro Mendez, JS
|
|
2009
|
12 |
Supplement 3 |
p. A517-
1 p.
|
artikel
|
| 149 |
PIN54 INCREASING CHC TREATMENT RATE IN US IS A COST-SAVING STRATEGY
|
Zhang, H
|
|
2009
|
12 |
Supplement 3 |
p. A119-
1 p.
|
artikel
|
| 150 |
PIN41 PREVENTION OF AN INFLUENZA PANDEMIC IN MEXICO: ESTABLISHING A COST-EFFECTIVE ALTERNATIVE FOR ELDERLY POPULATION
|
Baca-Muro, VI
|
|
2009
|
12 |
Supplement 3 |
p. A425-
1 p.
|
artikel
|
| 151 |
PIN68 PSYCHOMETRIC EVALUATION OF THE FUNCTIONAL ASSESSMENT OF HIV INFECTION (FAHl) QUESTIONNAIRE IN TWO CLINICAL PROGRAMMES
|
Gilet, H
|
|
2009
|
12 |
Supplement 3 |
p. A430-
1 p.
|
artikel
|
| 152 |
PIN1 STATISTICAL ANALYSIS OF MONONUCLEOSIS IN ADOLESCENTS
|
LaRue, CL
|
|
2009
|
12 |
Supplement 3 |
p. A109-
1 p.
|
artikel
|
| 153 |
PIN54 THE COST-EFFECTIVENESS OF THE NEW PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (PCVI3) FOR CHILDHOOD AND ADULT VACCINATION IN THE UK
|
Patel, R
|
|
2009
|
12 |
Supplement 3 |
p. A427-
1 p.
|
artikel
|
| 154 |
PIN9 THE COST OF PREVENTING INFLUENZA PANDEMIC: MEXICAN ELDERLY POPULATION SCENARIO
|
Soria-Cedillo, IF
|
|
2009
|
12 |
Supplement 3 |
p. A419-
1 p.
|
artikel
|
| 155 |
PIN18 THE ESTABLISHMENT OF A COST-EFFECTIVE ANTIBIOTIC TREATMENT OF INFECTIVE ENDOCARDITIS AND MRSA BACTEREMIA IN MEXICAN PUBLIC HEALTH CARE SYSTEM
|
Baca-Muro, VI
|
|
2009
|
12 |
Supplement 3 |
p. A113-
1 p.
|
artikel
|
| 156 |
PIN4 US HEPATITIS-C BURDEN ASSESSMENT FROM A TRANSMISSION MODEL
|
Zhang, H
|
|
2009
|
12 |
Supplement 3 |
p. A110-
1 p.
|
artikel
|
| 157 |
PMC55 AGREEMENT BETWEEN PATIENT AND PROXY ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE BEFORE INTENSIVE CARE UNIT ADMISSION
|
Vandijck, D
|
|
2009
|
12 |
Supplement 3 |
p. A397-
1 p.
|
artikel
|
| 158 |
PMC41 CONTROLLING FOR UNOBSERVABLE BIAS: IS THE CURE WORSE THAN THE DISEASE?
|
Baser, O
|
|
2009
|
12 |
Supplement 3 |
p. A394-
1 p.
|
artikel
|
| 159 |
PMC19 COST-EFFECTIVENESS OF PREVENTIVE CARE AND MEDICINES: DO AGING DISEASES OFFSET SAVINGS FROM MORBIDITY REDUCTION?
|
Gandjour, A
|
|
2009
|
12 |
Supplement 3 |
p. A22-
1 p.
|
artikel
|
| 160 |
PMC14 DETERMINING COSTS OF CONCOMITANT MEDICATIONS IN RANDOMIZED CLINICAL TRIALS: A CASE STUDY
|
Han, L
|
|
2009
|
12 |
Supplement 3 |
p. A22-
1 p.
|
artikel
|
| 161 |
PMC60 DETERMINING THE MINIMALLY IMPORTANT DIFFERENCES OF FOUR PREFERENCE-BASED HEALTH INDICES: A SIMULATION APPROACH
|
Luo, N
|
|
2009
|
12 |
Supplement 3 |
p. A30-
1 p.
|
artikel
|
| 162 |
PMC72 DEVELOPMENT OF THE ACCEPT© QUESTIONNAIRE TO ASSESS ACCEPTABILITY OF LONG TERM TREATMENTS: QUALITATIVE STEPS
|
Marant, C
|
|
2009
|
12 |
Supplement 3 |
p. A400-
1 p.
|
artikel
|
| 163 |
PMC58 EVALUATING THE INFLUENCE OF PHYSICAL ACTIVITY ON THE SOCIAL AND ENVIRONMENTAL DOMAINS OF QUALITY OF LIFE
|
Lin, WL
|
|
2009
|
12 |
Supplement 3 |
p. A397-
1 p.
|
artikel
|
| 164 |
PMC10 HOW TO MAKE USE OF AVAILABLE SURVIVAL EVIDENCE IN AN INDIRECT COMPARISON
|
Ouwens, M
|
|
2009
|
12 |
Supplement 3 |
p. A388-
1 p.
|
artikel
|
| 165 |
PMC33 IMPACT OF IGNORING CORRELATION BETWEEN INPUT PARAMETERS ON VARIANCE OF COST-UTILITY RATIOS
|
Kan, HJ
|
|
2009
|
12 |
Supplement 3 |
p. A25-
1 p.
|
artikel
|
| 166 |
PMC75 MEANINGFUL VERSUS USEABLE RESPONSES TO PREFERENCE SURVEYS: INSIGHTS INTO IMPROVING THE VALIDITY OF HEALTH UTILITY SCORES
|
Wittenberg, E
|
|
2009
|
12 |
Supplement 3 |
p. A33-
1 p.
|
artikel
|
| 167 |
PMC57 RELATIONSHIP BETWEEN QUALITY OF LIFE AND HEALTH-RELATED MEASURES INCLUDING SYMPTOMS, BIOCHEMICAL MARKERS AND TUMOR BURDEN
|
Vinik, EJ
|
|
2009
|
12 |
Supplement 3 |
p. A30-
1 p.
|
artikel
|
| 168 |
PMC24 SAMPSON: A HYBRID SIMULATION AND OPTIMIZATION MODEL FOR MANAGING SURGICAL RESOURCES AND REDUCING WAITING TIMES
|
Walker, HD
|
|
2009
|
12 |
Supplement 3 |
p. A391-
1 p.
|
artikel
|
| 169 |
PMC7 THE NATURE AND SCALE OF INADEQUATE REPORTING OF DICHOTOMOUS OUTCOMES FROM SIX SYSTEMATIC REVIEWS
|
Bhanderi, M
|
|
2009
|
12 |
Supplement 3 |
p. A388-
1 p.
|
artikel
|
| 170 |
PMC47 USE OF STABILIZED INVERSE PROPENSITY SCORES AS WEIGHTS TO DIRECTLY ESTIMATE RELATIVE RISK AND ITS CONFIDENCE INTERVALS
|
Xu, S
|
|
2009
|
12 |
Supplement 3 |
p. A28-
1 p.
|
artikel
|
| 171 |
PMH60 A CONCEPTUAL MODEL OF 'CLEAR THINKING' RELEVANT TO PATIENTS DIAGNOSED WITH SCHIZOPHRENIA
|
Bridges, JF
|
|
2009
|
12 |
Supplement 3 |
p. A362-
1 p.
|
artikel
|
| 172 |
PMH66 ANTIDEPRESSANTS AND ANTIPSYCHOTICS USE IN CHILDREN-HAS THE UTILIZATION CHANGED AFTER SAFETY WARNINGS?
|
Mehta, S
|
|
2009
|
12 |
Supplement 3 |
p. A185-
1 p.
|
artikel
|
| 173 |
PMH49 ASSESSMENT OF TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT SYMPTOMS OF ADHD: PATIENT CHARACTERISTICS AND RESOURCE UTILIZATION DATA FROM AN INTERNET-BASED SURVEY
|
Khan, SA
|
|
2009
|
12 |
Supplement 3 |
p. A181-A182
nvt p.
|
artikel
|
| 174 |
PMH1 COMPLIANCE WITH ANTIPSYCHOTIC DRUGS AND HOSPITALIZATION: A NESTED CASE-CONTROL ANALYSIS IN A COHORT OF PEOPLE WITH SCHIZOPHRENIA
|
Moisan, J
|
|
2009
|
12 |
Supplement 3 |
p. A350-
1 p.
|
artikel
|
| 175 |
PMH5 COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE IN SCHIZOPHRENIC PATIENTS
|
Elkis, H
|
|
2009
|
12 |
Supplement 3 |
p. A521-
1 p.
|
artikel
|
| 176 |
PMH32 COST OF SCHIZOPHRENIA IN FRANCE
|
Heider, D
|
|
2009
|
12 |
Supplement 3 |
p. A356-
1 p.
|
artikel
|
| 177 |
PMH29 DIFFERENCES IN HEALTH CARE USES AFTER TREATMENT OF DULOXETINE VERSUS OTHER ANTIDEPRESSANTS FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN VETERANS AFFAIRS HEALTH CARE NETWORK
|
Shi, L
|
|
2009
|
12 |
Supplement 3 |
p. A355-A356
nvt p.
|
artikel
|
| 178 |
PMH46 ESTIMATING THE COSTS OF PSYCHIATRIC HOSPITAL SERVICES IN NIGERIA; A CASE STUDY OF FEDERAL NEUROPSYCHIATRIC HOSPITAL ENUGU, SOUTH EAST NIGERIA
|
Ezenduka, CC
|
|
2009
|
12 |
Supplement 3 |
p. A359-
1 p.
|
artikel
|
| 179 |
PMH63 ESTIMATION OF A MULTI-ATTRIBUTE UTILITY FUNCTION FOR THE SPANISH VERSION OF THE TOOL QUESTIONNAIRE
|
Cordero, L
|
|
2009
|
12 |
Supplement 3 |
p. A362-A363
nvt p.
|
artikel
|
| 180 |
PMH52 EVALUATING CENTRAL NERVOUS SYSTEM DRUG LABELS FOR PATIENT-REPORTED OUTCOMES CLAIMS
|
Viswanathan, S
|
|
2009
|
12 |
Supplement 3 |
p. A182-
1 p.
|
artikel
|
| 181 |
PMH17 HEALTH CARE COSTS ASSOCIATED WITH TREATMENT OF BIPOLAR DISORDER USING A MOOD STABILIZER PLUS ADJUNCTIVE ARIPIPRAZOLE, QUETIAPINE, RISPERIDONE, OLANZAPINE OR ZIPRASIDONE
|
Jing, Y
|
|
2009
|
12 |
Supplement 3 |
p. A175-
1 p.
|
artikel
|
| 182 |
PMH15 INITIAL HIGH-DOSE PRESCRIPTION OF DULOXETINE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: DEMOGRAPHIC AND CLINICAL PREDICTORS
|
Liu, X
|
|
2009
|
12 |
Supplement 3 |
p. A353-
1 p.
|
artikel
|
| 183 |
PMH85 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN CHILDREN AND ADOLESCENTS
|
Xiao, X
|
|
2009
|
12 |
Supplement 3 |
p. A188-A189
nvt p.
|
artikel
|
| 184 |
PMH20 RETROSPECTIVE COHORT STUDY OF THE EFFECTS OF EARLY VERSUS LATE TREATMENT OF INSOMNIA IN PATIENTS INITIATING ANTI-DEPRESSANT MEDICATIONS
|
Delea, T
|
|
2009
|
12 |
Supplement 3 |
p. A176-
1 p.
|
artikel
|
| 185 |
PMH2 SCHIZOPHRENIA MODELING: FACTORS ASSOCIATED WITH THE RISK OF BEING IN A SPECIFIC DISEASE STATE
|
Dragomir, A
|
|
2009
|
12 |
Supplement 3 |
p. A520-
1 p.
|
artikel
|
| 186 |
PMH34 TREATMENT BURDEN AND COSTS OF LISDEXAMFETAMINE DIMESYLATE USERS COMPARED WITH USERS OF OTHER LONGACTING TREATMENTS IN PATIENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
|
Christensen, L
|
|
2009
|
12 |
Supplement 3 |
p. A178-A179
nvt p.
|
artikel
|
| 187 |
PMH2 USE OF HYPNOTICS/ANXIOLYTICS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: ASSOCIATIONS WITH CHRONIC PAIN, SLEEP DISORDERS, AND ANTIDEPRESSANT SELECTION
|
Liu, X
|
|
2009
|
12 |
Supplement 3 |
p. A172-
1 p.
|
artikel
|
| 188 |
PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN: A PROSPECTIVE ANALYSIS
|
Hughes, DA
|
|
2009
|
12 |
Supplement 3 |
p. A3-A4
nvt p.
|
artikel
|
| 189 |
PMS91 ADHERENCE IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO) TREATED WITH ORAL BISPHOSPHONATES IN GERMANY: A SYSTEMATIC REVIEW
|
Steinle, T
|
|
2009
|
12 |
Supplement 3 |
p. A450-
1 p.
|
artikel
|
| 190 |
PMS17 BUDGET IMPACT ANALYSIS OF REIMBURSEMENT OF ARAVA® (LEFLUNOMIDE) IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN POLAND
|
Kawalec, P
|
|
2009
|
12 |
Supplement 3 |
p. A436-
1 p.
|
artikel
|
| 191 |
PMS3 COMPARISON OF 3 COMORBIDITY MEASURES AFFECTING PHYSICAL FUNCTION AND QUALITY OF LIFE FOR PATIENTS WITH ANKYLOSING SPONDYLITIS
|
Gooch, K
|
|
2009
|
12 |
Supplement 3 |
p. A64-
1 p.
|
artikel
|
| 192 |
PMS63 COMPARISON OF STAFF RESOURCES AND PATIENT TIME REQUIRED FOR RITUXIMAB AND INFLIXIMAB ADMINISTRATION IN 3 UK NHS HOSPITALS
|
Scott, DGI
|
|
2009
|
12 |
Supplement 3 |
p. A445-
1 p.
|
artikel
|
| 193 |
PMS20 COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF INTRA-ARTICULAR SODIUM HYALURONATE VERSUS TOTAL ARTHROPLASTY IN THE TREATMENT OF KNEE OSTEOARTHRITIS UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
|
Fernandes, RA
|
|
2009
|
12 |
Supplement 3 |
p. A437-
1 p.
|
artikel
|
| 194 |
PMS35 COST-EFFECTIVENESS OF BIOLOGIC THERAPEUTIC SEQUENCES FOR RHEUMATOID ARTHRITIS IN THE UK
|
Emery, P
|
|
2009
|
12 |
Supplement 3 |
p. A439-
1 p.
|
artikel
|
| 195 |
PMS50 COST-MINIMIZATION ANALYSIS OF BISPHOSPHONATES FOR RISK REDUCTION OF POST-MENOPAUSE VERTEBRAL AND NON-VERTEBRAL FRACTURES UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL
|
Saggia, MG
|
|
2009
|
12 |
Supplement 3 |
p. A442-
1 p.
|
artikel
|
| 196 |
PMS9 COST-MINIMIZATION ANALYSIS OF VISCOSUPPLEMENTATION TREATMENT OSTEOARTHRITIS OF KNEE IN BRAZIL'S PRIVATE SECTOR
|
Bueno, RLP
|
|
2009
|
12 |
Supplement 3 |
p. A523-A524
nvt p.
|
artikel
|
| 197 |
PMS27 COSTS OF PSORIATIC ARTHRITIS IN HUNGARY; RESULTS FROM A CROSS-SECTIONAL SURVEY
|
Brodszky, V
|
|
2009
|
12 |
Supplement 3 |
p. A68-
1 p.
|
artikel
|
| 198 |
PMS53 ECONOMIC EVALUATION OF TRAMADOL/PARACETAMOL COMBINATION TABLETS VS NSAIDS FOR OSTEOARTHRITIS PAIN IN SPAIN
|
Vidal, J
|
|
2009
|
12 |
Supplement 3 |
p. A443-
1 p.
|
artikel
|
| 199 |
PMS4 EUROQOL-5 DIMENSION HEALTH STATUS QUESTIONNAIRE RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED PHASE 3 STUDY OF TAPENTADOL EXTENDED RELEASE (ER) FOR THE MANAGEMENT OF CHRONIC OSTEOARTHRITIS KNEE PAIN
|
Kavanagh, S
|
|
2009
|
12 |
Supplement 3 |
p. A433-A434
nvt p.
|
artikel
|
| 200 |
PMS45 EXTENSION FROM INPATIENTS TO OUTPATIENTS: PERFORMANCE OF THE OXFORD KNEE SCORE IN MEASURING HEALTH OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS
|
Xie, F
|
|
2009
|
12 |
Supplement 3 |
p. A72-
1 p.
|
artikel
|
| 201 |
PMS77 FURTHER DEVELOPMENTS OF THE RHEUMATOID ARTHRITIS QUALITY OF LIFE SCALE (RAQOL)
|
Wilburn, J
|
|
2009
|
12 |
Supplement 3 |
p. A447-A448
nvt p.
|
artikel
|
| 202 |
PMS48 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THREE PHASE 3 STUDIES
|
Buchanan, J
|
|
2009
|
12 |
Supplement 3 |
p. A72-
1 p.
|
artikel
|
| 203 |
PMS47 GOLIMUMAB SIGNIFICANTLY IMPROVES PRODUCTIVITY IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM THE PHASE 3 GO-RAISE STUDY
|
Braun, J
|
|
2009
|
12 |
Supplement 3 |
p. A72-
1 p.
|
artikel
|
| 204 |
PMS29 GOLIMUMAB SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED RESULTS FROM THREE PHASE 3 STUDIES
|
Buchanan, J
|
|
2009
|
12 |
Supplement 3 |
p. A69-
1 p.
|
artikel
|
| 205 |
PMS94 MANAGEMENT AND DIAGNOSIS OF OSTEOPOROTIC VERTEBRAL FRACTURES ACCORDING TO PRIMARY CARE PHYSICIANS
|
Palma Ruiz, M
|
|
2009
|
12 |
Supplement 3 |
p. A451-
1 p.
|
artikel
|
| 206 |
PMS17 NATIONAL COST OF ILLNESS STUDY COMPARING VETERAN PATIENTS WITH GOUT TO THOSE WITH DIFFICULT TO MANAGE GOUT
|
Raisch, DW
|
|
2009
|
12 |
Supplement 3 |
p. A66-
1 p.
|
artikel
|
| 207 |
PMS3 PROPORTION OF PATIENTS WITH OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN PERFORMING A BONE MINERAL DENSITY DIAGNOSIS MEASUREMENT: THE PRESAGE STUDY
|
Guggenbuhl, P
|
|
2009
|
12 |
Supplement 3 |
p. A433-
1 p.
|
artikel
|
| 208 |
PMS42 THE EFFECT OF LIFESTYLE CHOICES ON THE RISK OF IMPAIRMENT IN RHEUMATOID ARTHRITIS PATIENTS: AN ANALYSIS OF AEROBIC EXERCISE AND CIGARETTE SMOKING
|
Shah, A
|
|
2009
|
12 |
Supplement 3 |
p. A71-
1 p.
|
artikel
|
| 209 |
PND2 A BAYESIAN META-ANALYSIS COMPARING TREATMENTS FOR ALZHEIMER'S DISEASE
|
Gilligan, A
|
|
2009
|
12 |
Supplement 3 |
p. A365-
1 p.
|
artikel
|
| 210 |
PND43 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE AND RELAPSE IN THE PREVIOUS YEAR AMONG MULTIPLE SCLEROSIS PATIENTS: BASELINE DATA FROM ROBUST
|
Halper, J
|
|
2009
|
12 |
Supplement 3 |
p. A373-A374
nvt p.
|
artikel
|
| 211 |
PND46 A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR THE TREATMENT OF CIDP
|
Gaebel, K
|
|
2009
|
12 |
Supplement 3 |
p. A374-
1 p.
|
artikel
|
| 212 |
PND42 BRAZILIAN NATIONAL GUIDELINE FOR MULTIPLE SCLEROSIS (MS): AN EXPLORATORY STUDY ABOUT THE IMPACT OF THE PATIENT'S ADHERENCE IN THE TREATMENT COSTS
|
Bueno, RLP
|
|
2009
|
12 |
Supplement 3 |
p. A197-A198
nvt p.
|
artikel
|
| 213 |
PND12 COST AND RESOURCE USE RELATED TO NEWLY DIAGNOSED MULTIPLE SCLEROSIS: REAL-WORLD DATA FROM A LARGE US CLAIMS DATABASE
|
Singer, ME
|
|
2009
|
12 |
Supplement 3 |
p. A367-
1 p.
|
artikel
|
| 214 |
PND11 COST-EFFECTIVENESS OF SCREENING AND TREATMENT OF ALZHEIMER'S DISEASE WITH DONEPEZIL IN THE UNITED KINGDOM
|
Getsios, D
|
|
2009
|
12 |
Supplement 3 |
p. A191-
1 p.
|
artikel
|
| 215 |
PND14 COST OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS IN THE UNITED KINGDOM
|
Smalarz, A
|
|
2009
|
12 |
Supplement 3 |
p. A192-
1 p.
|
artikel
|
| 216 |
PND29 PARKINSON'S DISEASE DRUG THERAPIES: MEDICATION COMPLIANCE AND PERSISTENCE
|
Tarrants, ML
|
|
2009
|
12 |
Supplement 3 |
p. A371-
1 p.
|
artikel
|
| 217 |
PND28 THE USE OF ELECTRONIC PATIENT-REPORTED OUTCOMES WITHIN CENTRAL NERVOUS SYSTEM PROTOCOLS
|
Wenzel, K
|
|
2009
|
12 |
Supplement 3 |
p. A195-
1 p.
|
artikel
|
| 218 |
PP3 WHAT DIMENSIONS ARE IMPORTANT TO PATIENTS IN THEIR EXPERIENCE OF CONTINUITY OF CARE? A STUDY OF PATIENTS' PREFERENCES USING A DISCRETE CHOICE EXPERIMENT
|
Kjaer, T
|
|
2009
|
12 |
Supplement 3 |
p. A227-
1 p.
|
artikel
|
| 219 |
Prevention and Management of Hyperphosphatemia with Sevelamer in Canada: Health and Economic Consequences
|
Huybrechts, Krista F.
|
|
2009
|
12 |
Supplement 3 |
p. 16-19
4 p.
|
artikel
|
| 220 |
PRS12 ALLERGY IMMUNOTHERAPY CONFERS SIGNIFICANT HEALTH CARE COST SAVINGS WITHIN 3 MONTHS OF INITIATION: A MATCHED RETROSPECTIVE COHORT STUDY OF MEDICAID-ENROLLED CHILDREN NEWLY DIAGNOSED WITH ALLERGIC RHINITIS
|
Hankin, CS
|
|
2009
|
12 |
Supplement 3 |
p. A122-
1 p.
|
artikel
|
| 221 |
PRS38 CONTINUOUS TREATMENT WITH FIXED COMBINATION OF LABA/ICS CAN AVOID COSTS OF HOSPITALIZATION IN ASTHMA AND COPD IN GERMANY
|
Bonthapally, V
|
|
2009
|
12 |
Supplement 3 |
p. A128-
1 p.
|
artikel
|
| 222 |
PRS22 COST-EFFECTIVENESS ANALYSIS OF TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN SPAIN.
|
Brosa, M
|
|
2009
|
12 |
Supplement 3 |
p. A302-
1 p.
|
artikel
|
| 223 |
PRS49 FACTORS RELATED TO STOP SMOKING'S ATTEMPTS AMONG A FRENCH COHORT OF SMOKERS: (FOCUS STUDY)
|
Benhaddi, H
|
|
2009
|
12 |
Supplement 3 |
p. A308-
1 p.
|
artikel
|
| 224 |
PRS46 OFF-LABEL PRESCRIBING OF INHALED CORTICOSTEROID/ LONG ACTING BETA-AGONIST COMBINATION PRODUCTS IN COPD PATIENTS
|
Rigney, U
|
|
2009
|
12 |
Supplement 3 |
p. A307-
1 p.
|
artikel
|
| 225 |
PRS8 OPTIMA MODEL-BASED COST-UTILITY ANALYSIS OF FIXED COMBINATIONS SALMETEROL/FLUTICASONE VS. BUDESONIDE/FORMOTEROL IN TREATMENT OF ASTHMA IN RUSSIA
|
Kulikov, A
|
|
2009
|
12 |
Supplement 3 |
p. A300-
1 p.
|
artikel
|
| 226 |
PRS5 PRIMARY CARE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS FROM GENERAL PRACTICE DATABASE
|
Citarella, A
|
|
2009
|
12 |
Supplement 3 |
p. A299-
1 p.
|
artikel
|
| 227 |
PRS11 QUANTIFYING COSTS AND BENEFITS OF TIMING PHARMACEUTICAL INTERVENTION: AN ECONOMIC SIMULATION MODEL OF ASTHMA IN ALBERTA, CANADA
|
Thanh, NX
|
|
2009
|
12 |
Supplement 3 |
p. A122-
1 p.
|
artikel
|
| 228 |
PRS25 THE FINANCIAL IMPACT OF COMPUTER SYSTEMS–BASED APPROACHES TO REDUCING REPEAT DRUG EXPOSURE IN PATIENTS WITH KNOWN DRUG ALLERGIES
|
Huang, YF
|
|
2009
|
12 |
Supplement 3 |
p. A125-
1 p.
|
artikel
|
| 229 |
PRS28 TRENDS IN PREVALENCE OF OBESITY AND MEDICAL COSTS IN ASTHMA PATIENTS IN THE UNITED STATES
|
Choi, IS
|
|
2009
|
12 |
Supplement 3 |
p. A126-
1 p.
|
artikel
|
| 230 |
PRS36 XOLAIR QUALITY OF LIFE RESULTS AS MEASURED IN A BELGIAN OBSERVATIONAL STUDY IN PATIENTS WITH SEVERE ALLERGIC ASTHMA
|
Lecomte, P
|
|
2009
|
12 |
Supplement 3 |
p. A305-
1 p.
|
artikel
|
| 231 |
PSS40 CAN WE RELY ON SCORES FROM THE DERMATOLOGY LIFE QUALITY INDEX?
|
Twiss, J
|
|
2009
|
12 |
Supplement 3 |
p. A460-
1 p.
|
artikel
|
| 232 |
PSS16 CHARACTERIZING FUNCTIONAL LIMITATIONS FOR ADULTS WITH DIABETIC RETINOPATHY
|
Szabo, SM
|
|
2009
|
12 |
Supplement 3 |
p. A77-
1 p.
|
artikel
|
| 233 |
PSS9 COSTS OF PATIENTS WITH OCCUPATIONAL SEVERE CHRONIC HAND ECZEMA REFRACTORY TO TOPICAL CORTICOSTEROIDS FOR EMPLOYER'S MUTUAL INSURANCE COMPANIES IN SPAIN
|
Mascaro, JM
|
|
2009
|
12 |
Supplement 3 |
p. A453-A454
nvt p.
|
artikel
|
| 234 |
PSS19 DEVELOPMENT AND VALIDATION OF PATIENT-REPORTED OUTCOMES (PRO) TOOL FOR EYELASH CHARACTERISTICS
|
Hammond, GC
|
|
2009
|
12 |
Supplement 3 |
p. A78-
1 p.
|
artikel
|
| 235 |
PSS43 EVALUATION OF THE IMPLEMENTATION OF UK NATIONAL GUIDANCE ON THE USE OF BIOLOGICS IN SEVERE PSORIASIS
|
Bewley, A
|
|
2009
|
12 |
Supplement 3 |
p. A460-
1 p.
|
artikel
|
| 236 |
PSS26 EXPECTED VALUE OF PARTIAL PERFECT INFORMATION IN A MARKOV MODEL OF INFLIXIMAB AND ETANERCEPT IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE TYPE PSORIASIS
|
Visser, MS
|
|
2009
|
12 |
Supplement 3 |
p. A457-
1 p.
|
artikel
|
| 237 |
PSS1 META-ANALYSIS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
|
Hawkins, NS
|
|
2009
|
12 |
Supplement 3 |
p. A74-A75
nvt p.
|
artikel
|
| 238 |
PSY42 BLEEDING DISORDERS, MENORRHAGIA AND IRON DEFICIENCY: AN EXAMINATION OF QUALITY OF LIFE
|
Horsman, JR
|
|
2009
|
12 |
Supplement 3 |
p. A383-
1 p.
|
artikel
|
| 239 |
Psychometric Development and Validation of the Chronic Constipation Treatment Satisfaction Questionnaire (CTSAT-Q)
|
Szeinbach, Sheryl L.
|
|
2009
|
12 |
Supplement 3 |
p. 1004-1010
7 p.
|
artikel
|
| 240 |
PSY19 COST-EFFECTIVENESS COMPARISON ANALYSIS OF ANTI-TNF AGENTS WITH MULTIPLE INDICATIONS
|
Szkurhan, AR
|
|
2009
|
12 |
Supplement 3 |
p. A133-
1 p.
|
artikel
|
| 241 |
PSY11 DEFI (DETERMINATION OF EPIDEMIOLOGY OF FIBROMYALGIA) A FRENCH PREVALENCE STUDY OF FIBROMYALGIA
|
Kosa, M
|
|
2009
|
12 |
Supplement 3 |
p. A377-
1 p.
|
artikel
|
| 242 |
PSY22 ECONOMIC EVALUATION OF RECOMBINANT FACTOR VIII PRODUCTS IN TREATMENT OF HAEMOPHILIA A. IN KOREA
|
Kim, JY
|
|
2009
|
12 |
Supplement 3 |
p. A134-
1 p.
|
artikel
|
| 243 |
PSY28 IRON DEFICIENCY IN SWEDEN—TREATMENT OPTIONS, COSTEFFECTIVENESS AND REIMBURSEMENT
|
Glenngârd, AH
|
|
2009
|
12 |
Supplement 3 |
p. A380-
1 p.
|
artikel
|
| 244 |
PSY25 RENAL ANEMIA (RA) TREATMENT IN MEXICAN PUBLIC HEALTH CARE INSTITUTIONS: AN EVALUATION OF THE COSTS AND CONSEQUENCES
|
Gonzalez, P
|
|
2009
|
12 |
Supplement 3 |
p. A379-A380
nvt p.
|
artikel
|
| 245 |
PSY56 SYSTEMATIC REVIEW OF THE DIRECT COSTS RELATED TO OBESITY AND ASSOCIATED DISEASES IN POLAND
|
Perkowski, P
|
|
2009
|
12 |
Supplement 3 |
p. A386-
1 p.
|
artikel
|
| 246 |
PSY36 THE HEALTH BURDEN OF NEUROPATHIC PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS OF HEALTH UTILITIES
|
Taylor, RS
|
|
2009
|
12 |
Supplement 3 |
p. A136-A137
nvt p.
|
artikel
|
| 247 |
PSY5 THE USEFULNESS OF REGISTRY DATA FOR UNDERSTANDING TREATMENT PRACTICES AND CLINICAL OUTCOMES IN HEMOPHILIA: THE EXPERIENCE OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY (2004–2008)
|
Kessler, CM
|
|
2009
|
12 |
Supplement 3 |
p. A130-
1 p.
|
artikel
|
| 248 |
PUK3 CALCIUM-BASED PHOSPHATE BINDERS LEAD TO INCREASED PROGRESSION OF VASCULAR CALCIFICATION IN CHRONIC KIDNEY DISEASE
|
Beard, K
|
|
2009
|
12 |
Supplement 3 |
p. A198-
1 p.
|
artikel
|
| 249 |
PUK18 PATIENT PREFERENCE FOR TAMSULOSIN OCAS (ORAL CONTROLLED ABSORPTION SYSTEM) OVER TAMSULOSIN MODIFIED RELEASE CAPSULES
|
Khastgir, J
|
|
2009
|
12 |
Supplement 3 |
p. A201-
1 p.
|
artikel
|
| 250 |
PUK15 STRESS URINARY INCONTINENCE: ASSESSMENT OF WOMEN'S PREFERENCES
|
Riou França, L
|
|
2009
|
12 |
Supplement 3 |
p. A310-A311
nvt p.
|
artikel
|
| 251 |
Relapse and Long-Acting Injectable Risperidone: A 1-Year Mirror Image Study with a National Claims Database in Taiwan
|
Su, Kuan-Pin
|
|
2009
|
12 |
Supplement 3 |
p. S118-S121
4 p.
|
artikel
|
| 252 |
Reliability of the Discrete Choice Experiment at the Input and Output Level in Patients with Rheumatoid Arthritis
|
Skjoldborg, Ulla Slothuus
|
|
2009
|
12 |
Supplement 3 |
p. 153-158
6 p.
|
artikel
|
| 253 |
RR4 OUTCOMES ASSOCIATED WITH TIOTROPIUM USE IN COPD PATIENTS
|
Lee, TA
|
|
2009
|
12 |
Supplement 3 |
p. A19-
1 p.
|
artikel
|
| 254 |
The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
|
Cherry, Spencer B.
|
|
2009
|
12 |
Supplement 3 |
p. 489-497
9 p.
|
artikel
|
| 255 |
The Costs of Care in Atrial Fibrillation and the Effect of Treatment Modalities in Germany
|
McBride, Doreen
|
|
2009
|
12 |
Supplement 3 |
p. 293-301
9 p.
|
artikel
|
| 256 |
The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial
|
Skedgel, Chris
|
|
2009
|
12 |
Supplement 3 |
p. 641-648
8 p.
|
artikel
|
| 257 |
The Effect of Waiting Time on Health-Related Quality of Life, Pain, and Physical Function in Patients Awaiting Primary Total Hip Replacement: A Randomized Controlled Trial
|
Hirvonen, Johanna
|
|
2009
|
12 |
Supplement 3 |
p. 942-947
6 p.
|
artikel
|
| 258 |
The Health Value and Cost of Care for Major Depression
|
Watkins, Katherine E.
|
|
2009
|
12 |
Supplement 3 |
p. 65-72
8 p.
|
artikel
|
| 259 |
The Willingness to Pay for Reducing Pain and Pain-Related Disability
|
Chuck, Anderson
|
|
2009
|
12 |
Supplement 3 |
p. 498-506
9 p.
|
artikel
|
| 260 |
Using the Rasch Model to Validate and Enhance the Interpretation of the Functional Assessment of Cancer Therapy–Kidney Symptom Index—Disease-Related Symptoms Scale
|
Luo, Xuemei
|
|
2009
|
12 |
Supplement 3 |
p. 580-586
7 p.
|
artikel
|
| 261 |
Utility Estimates for Decision–Analytic Modeling in Chronic Heart Failure—Health States Based on New York Heart Association Classes and Number of Rehospitalizations
|
Göhler, Alexander
|
|
2009
|
12 |
Supplement 3 |
p. 185-187
3 p.
|
artikel
|
| 262 |
VA3 A GLOBAL COST-EFFECTIVENESS EVALUATION OF THE IMPACT OF POTENTIAL INNOVATIONS IN MEASLES VACCINATION
|
Garrison, LP
|
|
2009
|
12 |
Supplement 3 |
p. A9-
1 p.
|
artikel
|
| 263 |
Value of Information and Value of Implementation: Application of an Analytic Framework to Inform Resource Allocation Decisions in Metastatic Hormone-Refractory Prostate Cancer
|
Hoomans, Ties
|
|
2009
|
12 |
Supplement 3 |
p. 315-324
10 p.
|
artikel
|
| 264 |
Valuing Condition-Specific Health States Using Simulation Contact Lenses
|
Czoski-Murray, Carolyn
|
|
2009
|
12 |
Supplement 3 |
p. 793-799
7 p.
|
artikel
|
| 265 |
What Is the Best Strategy for Diagnosis and Treatment of Helicobacter pylori in the Prevention of Recurrent Peptic Ulcer Bleeding? A Cost-Effectiveness Analysis
|
Gené, Emili
|
|
2009
|
12 |
Supplement 3 |
p. 759-762
4 p.
|
artikel
|
| 266 |
Why Do Patients with Inflammatory Arthritis Often Score States “Worse than Death” on the EQ-5D? An Investigation of the EQ-5D Classification System
|
Harrison, Mark J.
|
|
2009
|
12 |
Supplement 3 |
p. 1026-1034
9 p.
|
artikel
|
| 267 |
WP4 DISCRETE CHOICE EXPERIMENT TO DETERMINE WILLINGNESS-TO-PAY FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
|
Ciobanu, A
|
|
2009
|
12 |
Supplement 3 |
p. A237-
1 p.
|
artikel
|
Tijdschrift beschrijving